S. Elsayed

Morin mitigates doxorubicin-induced cardiotoxicity via suppression of oxidative stress, inflammation, and structural remodeling.

The clinical use of the anticancer drug doxorubicin is restricted by its ability to cause cardiotoxicity, often progressing to heart failure. Current cardiovascular treatments fail to restore cardiac function or improve long-term survival rates, demanding alternative therapeutic approaches to minimize the cardiotoxicit...